Subtopic Deep Dive
Uterine Leiomyoma Pathogenesis
Research Guide
What is Uterine Leiomyoma Pathogenesis?
Uterine leiomyoma pathogenesis encompasses the genetic mutations, hormonal influences, and molecular signaling pathways driving fibroid development in reproductive-aged women.
Uterine leiomyomas affect up to 80% of women by age 50, with key drivers including MED12 mutations in over 70% of cases (Markowski et al., 2012, 213 citations) and chromothripsis-like rearrangements (Mehine et al., 2013, 338 citations). Racial disparities show higher prevalence and severity in Black women (Stewart et al., 2017, 995 citations; Al-Hendy et al., 2017, 237 citations). Over 10 papers from 2005-2019 detail these mechanisms, with 545-995 citations each.
Why It Matters
Pathogenesis insights identify therapeutic targets like MED12 and progesterone pathways, reducing hysterectomy reliance (Walker and Stewart, 2005, 545 citations). Understanding chromothripsis and gene expression changes (Mehine et al., 2013; Arslan et al., 2005, 194 citations) enables precision medicine for 70-80% of affected women. Racial disparity data (Stewart et al., 2017; Al-Hendy et al., 2017) guide equitable interventions, impacting fertility and morbidity.
Key Research Challenges
Heterogeneity of Mutations
Fibroids show diverse drivers like MED12 mutations in 70% but cytogenetic changes in only 20% (Markowski et al., 2012). Whole-genome sequencing reveals chromothripsis in subsets (Mehine et al., 2013). Linking variants to clinical outcomes remains unresolved.
Racial Disparity Mechanisms
Black women face 2-3x higher prevalence and severity due to genetic-environmental factors (Al-Hendy et al., 2017; Stewart et al., 2017). Epigenetic and hormonal influences need dissection. No unified model explains disparities.
Hormonal Pathway Integration
Progesterone and steroid receptors drive growth, interacting with endometrium (Ciavattini et al., 2013; Yilmaz and Bulun, 2019). Gene expression links IGF, TGF-beta, and retinoids (Arslan et al., 2005). Integrating with genetic hits is incomplete.
Essential Papers
Epidemiology of uterine fibroids: a systematic review
Elizabeth A. Stewart, CL Cookson, RA Gandolfo et al. · 2017 · BJOG An International Journal of Obstetrics & Gynaecology · 995 citations
Background Uterine fibroids ( UF s) are the most common neoplasm affecting women that can cause significant morbidity and may adversely impact fertility. Objectives To examine UF epidemiology and t...
Uterine Fibroids: The Elephant in the Room
Cheryl L. Walker, Elizabeth A. Stewart · 2005 · Science · 545 citations
Uterine fibroids (leiomyomas) have historically been viewed as important chiefly as the major indication for hysterectomy. As new therapies are developed, the heterogeneity of this disease becomes ...
Characterization of Uterine Leiomyomas by Whole-Genome Sequencing
Miika Mehine, Eevi Kaasinen, Netta Mäkinen et al. · 2013 · New England Journal of Medicine · 338 citations
Chromosome shattering and reassembly resembling chromothripsis (a single genomic event that results in focal losses and rearrangements in multiple genomic regions) is a major cause of chromosomal a...
Uterine Fibroids: Burden and Unmet Medical Need
Ayman Al‐Hendy, Evan R. Myers, Elizabeth A. Stewart · 2017 · Seminars in Reproductive Medicine · 237 citations
Abstract Uterine fibroids affect a wide cross-section of the population, with prevalence, symptom severity, and overall disease burden generally higher among black women, likely due to both genetic...
Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms
Michael A. Seidman, Titilope Oduyebo, Michael G. Muto et al. · 2012 · PLoS ONE · 232 citations
While additional study is warranted, these data suggest uterine morcellation carries a risk of disseminating unexpected malignancy with apparent associated increase in mortality much higher than ap...
Endometriosis and nuclear receptors
Bahar D. Yilmaz, Serdar E. Bulun · 2019 · Human Reproduction Update · 227 citations
Abstract BACKGROUND Endometriosis is recognized as a steroid-dependent disorder; however, the precise roles of nuclear receptors (NRs) in steroid responsiveness and other signaling pathways are not...
<i>MED12</i> mutations in uterine fibroids—their relationship to cytogenetic subgroups
Dominique Nadine Markowski, Sabine Bartnitzke, Thomas Löning et al. · 2012 · International Journal of Cancer · 213 citations
Abstract Recurrent chromosomal alterations are found in roughly 20% of all uterine fibroids but in the majority cytogenetic changes are lacking. Recently, mutations of the gene mediator subcomplex ...
Reading Guide
Foundational Papers
Start with Walker and Stewart (2005, 545 citations) for disease heterogeneity overview; Mehine et al. (2013, 338 citations) for genomic mechanisms; Markowski et al. (2012, 213 citations) for MED12 mutations establishing genetic paradigms.
Recent Advances
Stewart et al. (2017, 995 citations) for epidemiology; Al-Hendy et al. (2017, 237 citations) for burden and disparities; Yilmaz and Bulun (2019, 227 citations) for nuclear receptor roles.
Core Methods
Whole-genome sequencing (Mehine et al., 2013); gene expression microarrays (Arslan et al., 2005); cytogenetic subgrouping (Markowski et al., 2012); systematic reviews (Stewart et al., 2017).
How PapersFlow Helps You Research Uterine Leiomyoma Pathogenesis
Discover & Search
Research Agent uses searchPapers and citationGraph to map MED12 mutation literature from Markowski et al. (2012), revealing 213 citing papers on cytogenetic subgroups. exaSearch uncovers racial disparity studies like Stewart et al. (2017, 995 citations), while findSimilarPapers expands from Mehine et al. (2013) chromothripsis findings.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation frequencies from Mehine et al. (2013), then verifyResponse (CoVe) cross-checks claims against Stewart et al. (2017). runPythonAnalysis computes citation trends or prevalence stats from exported CSV, with GRADE grading for evidence strength in pathogenesis claims.
Synthesize & Write
Synthesis Agent detects gaps in MED12-hormone integration post-Ciavattini et al. (2013), flagging contradictions via exportMermaid diagrams of pathways. Writing Agent uses latexEditText, latexSyncCitations for fibroid review drafts, and latexCompile for publication-ready outputs with synced references.
Use Cases
"Analyze mutation frequencies across uterine fibroid genomics papers using Python."
Research Agent → searchPapers('MED12 uterine leiomyoma') → Analysis Agent → readPaperContent(Mehine 2013) + runPythonAnalysis(pandas frequency plot) → matplotlib prevalence graph.
"Draft LaTeX review on fibroid pathogenesis with citations."
Synthesis Agent → gap detection (post-Walker 2005) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Stewart 2017 et al.) → latexCompile(PDF output).
"Find code for chromothripsis analysis in leiomyoma WGS data."
Research Agent → paperExtractUrls(Mehine 2013) → paperFindGithubRepo → Code Discovery → githubRepoInspect(scripts) → runPythonAnalysis(local sandbox test).
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'uterine leiomyoma MED12', producing structured reports with GRADE-scored pathogenesis mechanisms from Mehine et al. (2013). DeepScan applies 7-step CoVe to verify racial disparity claims (Al-Hendy et al., 2017), checkpointing mutation stats. Theorizer generates hypotheses linking chromothripsis to progesterone signaling from Walker and Stewart (2005).
Frequently Asked Questions
What defines uterine leiomyoma pathogenesis?
Genetic mutations like MED12 (Markowski et al., 2012), chromothripsis (Mehine et al., 2013), hormonal drivers, and signaling pathways (Ciavattini et al., 2013) initiate benign uterine tumors.
What are key methods in pathogenesis studies?
Whole-genome sequencing detects chromothripsis (Mehine et al., 2013); gene expression profiling identifies IGF/TGF-beta pathways (Arslan et al., 2005); cytogenetic analysis links MED12 to subgroups (Markowski et al., 2012).
What are major papers on fibroid pathogenesis?
Walker and Stewart (2005, 545 citations) highlight heterogeneity; Mehine et al. (2013, 338 citations) detail genomic shattering; Markowski et al. (2012, 213 citations) confirm MED12 mutations.
What open problems exist?
Integrating genetics with hormonal/epigenetic factors; explaining racial disparities beyond prevalence (Al-Hendy et al., 2017); modeling tumor-endometrium interactions (Ciavattini et al., 2013).
Research Uterine Myomas and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Uterine Leiomyoma Pathogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Uterine Myomas and Treatments Research Guide